Your session is about to expire
← Back to Search
Cannabis Components for Bipolar Disorder
Study Summary
This trial will study the effects of cannabis on people with bipolar disorder to see if it affects cognition. They will test different doses of two major components of cannabis, cannabidiol and ∆9-tetrahydrocannabinol, and compare them to placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Subjects in the BD group must meet DSM-5 criteria for Bipolar Disorder as ascertained by the Structured Clinical Interview for DSM-5 (SCID).Your score on the Young Mania Rating Scale is less than 12, indicating a lower likelihood of manic episodes.I use cannabis no more than 4 times a month.You abstain from cannabis use for a minimum of two days before the study appointment.I do not have serious heart, liver, kidney, blood pressure, or lung problems and am not pregnant or breastfeeding.I have a skin infection where a spinal tap would be performed.I do not have a history of major neurological disorders or significant head injuries.I can walk on my own without needing a wheelchair and do not have a motor disease.I am willing to use birth control during the study.I do not have any active infections or cancers needing immediate treatment.
- Group 1: Bipolar Disorder
- Group 2: Healthy Volunteers
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other research efforts have been undertaken with respect to Dronabinol?
"Currently, 19 trials for Dronabinol are in Phase 3 and 104 studies overall. While Belmont, Massachusetts is a hub of research activity on the compound, 331 sites across the world are currently conducting investigations into its efficacy."
Does this research program accept elderly participants?
"Per the study's rules, enrolment requires that participants are aged between 18 and 50 years."
Is joining this research endeavor open to me?
"The qualifications to join this clinical trial are manic disorder and being between 18-50 years old. It is expected that around 144 patients will be admitted into the study."
Is participation in this clinical research endeavor still available?
"According to clinicaltrials.gov, this research has been ongoing since September 1st 2021 and is currently in search of patients. The most recent update was made on June 23rd 2022."
What diseases have been alleviated with the application of Dronabinol?
"Dronabinol is largely implemented as a treatment of last resort due to its efficacy in treating multiple sclerosis, pharmacotherapy, and pain."
To what extent can this research be conducted with test subjects?
"Affirmative, the information available on clinicaltrials.gov shows that this study is in its recruitment phase. It was initialy advertised on September 1st 2021 and recently revised on June 23rd 2022. The research team seeks to enrol 144 patients from a single healthcare centre."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- UC San Diego Medical Center: < 24 hours
Average response time
- < 1 Day
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger